HOME >> BIOLOGY >> NEWS
Pan-African Malaria Conference November 17-22 in Arusha, Tanzania

National Institutes of Health, Bethesda, Maryland -- The Fogarty International Center (FIC) of the National Institutes of Health (NIH) announces the Third Pan-African Malaria Conference of the Multilateral Initiative on Malaria (MIM). The MIM conference, now open to members of the media, will be held November 17 to 22, 2002, in Arusha, Tanzania.

The MIM conference will bring together malaria researchers from across Africa and around the world to consider malaria research advances, how to more effectively employ or develop malaria-control strategies, and how to strengthen malaria research training activities. More than 700 malaria researchers and control experts will attend the MIM conference.

MIM is an international alliance of research and public health agencies and African scientists established in 1997 in Dakar, Senegal, at the first Pan-African Malaria Conference. MIM's objectives are to stimulate and support collaborative research to address the needs of public health programs in malaria-endemic countries and to strengthen research capacity in malaria-endemic countries. FIC, which serves as the current MIM Secretariat, organized the conference on behalf of the MIM partners.

Public and private groups are co-sponsoring the conference. Major sponsors include the NIH (the Fogarty International Center, the National Institute of Allergy and Infectious Diseases, the National Institute of Environmental Health Sciences, and the National Library of Medicine), the Bill & Melinda Gates Foundation, GlaxoSmithKline, the German Federal Ministry for Education and Research, the Malaria Vaccine Initiative, the Swiss Development Cooperation, the United States Agency for International Development, the World Health Organization, The Wellcome Trust, and the UK Medical Research Council. A complete list of partners is available on the MIM website at http://mim.nih.gov.

Malaria kills 2.7 million people each year, mo
'"/>

Contact: Irene Edwards
edwardsi@mail.nih.gov
301-496-2075
NIH/Fogarty International Center
16-Oct-2002


Page: 1 2

Related biology news :

1. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
2. Malaria rise in Africa parallels warming trends
3. Multilateral Initiative on Malaria Secretariat to move to Sweden
4. Malaria research and training benefits global community
5. Malaria called failure, puzzle and challenge
6. Multicomponent Malaria Vaccine Shows Promise in Laboratory Tests
7. Christmas Travellers Are Warned Of Malaria Risks
8. Genetic Code Of Chromosome Of Malaria Parasite Deciphered
9. Virginia Tech Scientist Seek Genetic Solution To Malaria
10. Severe Falciparum Malaria Increases In Honduras
11. Curing Malaria, Controlling Mosquitoes Symposium Set For AAAS Meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for ... Approval of this IND allows Sentien to initiate a Phase 1/2 study with ...
(Date:8/21/2020)... (PRWEB) , ... August 20, 2020 , ... ... that Hassan Movahhed , a Clinical Operations executive with expertise in clinical ... has joined the firm as an Expert Consultant. Throughout his career, Mr. Movahhed ...
(Date:8/7/2020)... ... August 06, 2020 , ... ... is pleased to announce that Eric Chen and Jessica Wong have joined the ... Management & Strategy, respectively. , Eric Chen heads development efforts for Alucio’s flagship ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... The ... the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with ... network is a consortium of academic research centers in the United States and ...
(Date:8/7/2020)... ... 06, 2020 , ... VGXI, a highly regarded CDMO supporting ... purchase of greenfield for a new, expanded manufacturing facility. The site is located ... the initial acquisition, with an option to purchase an additional 21 acres for ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering ... 50 million stem cells total, patients may choose which extremities they would like treated. ... joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... that can combine up to three different materials for use with CRM, neurostimulation, ... up to three materials to meet specific design requirements, performance, and cost criteria; ...
Breaking Biology Technology:
Cached News: